Fact CheckerSign in

NCT07226908Enrolling by invitation

Human Thalamus in Propagation of Temporal Lobe Seizures and Memory Formation

Source: ClinicalTrials.gov · Last updated 12 Nov 2025

Brief summary (registry, in English)

The goal of the study is to examine how two key subregions of the human thalamus (ANT and PLV) are connected with other brain structures (Aim 1), how seizures involve the two thalamic subregions differently and how the map of cortico-thalamic ictal propagation matches the intrinsic connectivity maps identified in the same individuals (Aim 2), and the effect of ANT and PLV stimulations on memory formation (Aim 3).

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
100 (estimated)
First submitted
11 Aug 2025
Start date
1 Sept 2024
Primary completion date
31 Aug 2029
Lead sponsor
Stanford University
Diseases
Epilepsy
NCT number
NCT07226908

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Sept 2024 to the primary completion date, 31 Aug 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unable to provide informed consent

Who the study is looking for

  • No medical or surgical contraindication to electrode implantation
  • Patient capable of understanding the scope of our project or signing informed consent independently

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford Hospital
Coordinator of this site? Confirm its status
StanfordUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.